Processing

Please wait...

Settings

Settings

Goto Application

1. WO2012061931 - USE OF GENIPOSIDE IN DIABETES PREVENTION

Publication Number WO/2012/061931
Publication Date 18.05.2012
International Application No. PCT/CA2011/001246
International Filing Date 10.11.2011
IPC
A61K 31/7048 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 39/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
39General protective or antinoxious agents
A61P 5/50 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
5Drugs for disorders of the endocrine system
48of the pancreatic hormones
50for increasing or potentiating the activity of insulin
C07H 17/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
17Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
04Heterocyclic radicals containing only oxygen as ring hetero atoms
CPC
A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin ; digitoxin or digoxin
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 39/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
39General protective or antinoxious agents
A61P 5/50
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
5Drugs for disorders of the endocrine system
48of the pancreatic hormones
50for increasing or potentiating the activity of insulin
Applicants
  • NATIONAL RESEARCH COUNCIL OF CANADA [CA]/[CA] (AllExceptUS)
  • WANG, Yanwen [CA]/[CA] (UsOnly)
  • ZHANG, Junzeng [CA]/[CA] (UsOnly)
  • ZIDICHOUSKI, Jeffrey [CA]/[CA] (UsOnly)
  • LIU, Jianhui [CN]/[CN] (UsOnly)
  • YIN, Fei [CN]/[CN] (UsOnly)
Inventors
  • WANG, Yanwen
  • ZHANG, Junzeng
  • ZIDICHOUSKI, Jeffrey
  • LIU, Jianhui
  • YIN, Fei
Agents
  • PATENAUDE, Sonia
Priority Data
61/412,96612.11.2010US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF GENIPOSIDE IN DIABETES PREVENTION
(FR) UTILISATION DE GÉNIPOSIDE DANS LA PRÉVENTION DU DIABÈTE
Abstract
(EN)
The present invention relates to the use of a natural compound in diabetes prevention. More specifically, the invention relates to the use of geniposide as a pancreatic beta cell protectant for diabetes prevention and treatment.
(FR)
L'invention concerne l'utilisation d'un composé naturel dans la prévention du diabète. Plus spécifiquement, l'invention concerne l'utilisation de géniposide comme agent protecteur des cellules bêta pancréatiques pour prévenir et traiter le diabète.
Latest bibliographic data on file with the International Bureau